Ceftop 250 mg/250 mg Injection
By Ceftop
Rx
1 Injection in a Vial

Composition
Cefoperazone(250mg) + Sulbactam(250mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
September, 2025

liver
Limited information is currently available regarding the use of Ceftop 250 mg/250 mg Injection in individuals with liver disease. It is important to consult with your doctor before using this medication to ensure it is safe for you. Your doctor will be able to provide personalized guidance based on your specific liver condition and overall health.

kidney
Limited information is available on using Ceftop 250 mg/250 mg Injection in patients with kidney disease. Please consult your doctor for guidance.

alcohol
When using Ceftop 250 mg/250 mg Injection, avoid alcohol as it can lead to unwanted effects such as flushing, increased heart rate, nausea, chest pain, thirst, and low blood pressure (Disulfiram reaction).

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Ceftop 250 mg/250 mg Injection.

pregnancy
Ceftop 250 mg/250 mg Injection is generally safe during pregnancy, as animal studies show minimal negative effects on the developing baby. Limited human studies are available.

breastfeeding
Ceftop 250 mg/250 mg Injection is safe to use while breastfeeding. Research shows the medication does not pass into breastmilk in significant amounts, posing no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹117.91
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024